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EDITORIALGlial Orchestrated Neurodegeneration: An Important Crossroad
for Neural Stem Cell Therapy to the Intestineonventional wisdom teaches us that glia protectFigure 1. Neuronal-glia ineractions during intestinal
inﬂammation and neural stem cell transfer. ATP, adeno-
sine triphosphate; NO, nitric oxide; P2X7R, purinergic
receptor P2X, ligand gated ion channel, 7.Cneurons in the human body. For more than a cen-
tury, physicians and scientists have argued that glia provide
the fundamental infrastructure and life support to neurons,
without which the brain and intestine rapidly transcend into
chaos. But what if popular consensus is wrong and our glial
chaperones secretly monitor for epigenetic clues that
determine whether a neuron will live or die? In this issue of
Cellular and Molecular Gastroenterology and Hepatology, 2
independent reports provide new mechanistic insight into
how enteric neurons survive during intestinal inﬂammation
and after neural stem cell therapy. Both studies pose
interesting and immediate questions about the rationale for
intestinal autologous neural transplantation, which gener-
ally assumes that host immune function is the biggest ad-
versary to prolonged neural stem cell survival in the enteric
nervous system.
Enteric neuropathy is associated with wide-ranging
intestinal pathology and dysmotility: epitomized by in-
ﬂammatory bowel disease and aganglionic bowel failure in
Hirschsprung’s disease when embryonic neural crest cells
fail to colonize the distal colon. Autologous neural stem cells
are actively being explored as clinical therapy for Hirsch-
sprung’s disease and hold much promise based on treat-
ment successes already reported for hematopoietic and
cardiac disease. Unlike allogenic stem cell therapy in which
the recipient and donor are different people, autologous
transplantation removes, expands, and later gives back stem
cells to the same person to avoid immune rejection. In a
mechanistic proof-of-concept study, Rollo et al1 signiﬁcantly
advance our understanding of potential barriers to autolo-
gous enteric neural therapy by showing that p75þ stem
cells can be isolated and cultured from postnatal Hirsch-
sprung’s colon using simulated Wnt-driven signaling.
Importantly, expanded enteric neural stem cells retain the
capacity to proliferate and colonize avian embryonic intes-
tine, as well as postnatal aganglionic colon muscle cultures
from the same patient. The investigators also conﬁrm earlier
reports that aneuronal colonic tissues from Hirschsprung’s
patients harbor a rich network of neuronal precursors and
glia. These ﬁndings are encouraging because they show
in vitro feasibility for postnatal autologous neural cell
transfer in Hirschsprung’s patients, but raise new questions.
Are functional synapses formed in postnatal intestine after
autologous neural stem cell transfer? Are non-neural cells in
neurosphere cultures required for stem cell expansion?
What is the origin of neural precursors and glia identiﬁed in
aneuronal colon from Hirschsprung’s patients? Sacral neural
crest and glial stem cells are potential alternative neural
sources, but why do these precursors not differentiate in theCcolon? Do neural precursors identiﬁed in these aganglionic
sites also expand and colonize in vitro models? Such ﬁnd-
ings could indicate that neurons preferentially are elimi-
nated as they differentiate, possibly by resident glial cells
(Figure 1). Further studies are needed to establish exactly
how receptive postnatal Hirschsprung’s colon is to longer-
term neural stem cell survival, especially because cellular
proliferation markers such as 5-ethynyl-20-deoxyuridine
measure both DNA synthesis and alternate nucleotide
salvage pathways associated with DNA repair and cell death.
Glial-driven killing of enteric neurons was shown in an
elegant study by Brown et al2 in the same issue of Cellular
and Molecular Gastroenterology and Hepatology. Taking a
lead from astrocyte biology in the central nervous system,
the investigators showed that acute purine release from
glial hemichannels mediate cell death signals to enteric
neurons via activation of purinergic receptor P2X, ligand
gated ion channel, 7 receptors. Mechanistically, a signaling
cascade is initiated by extracellular adenosine diphosphate
action on glial P2Y1 receptors that triggers connexin-
47–dependent adenosine triphosphate release, which is
rapidly toxic to enteric neurons. This purinergic feedbackellular and Molecular Gastroenterology and Hepatology 2016;2:9–10
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generated nitric oxide, which contributes signiﬁcantly to-
ward enteric neuronal loss in vitro and in vivo. Although
further work is required to establish whether nitric oxide
signals also sensitize P2X7 receptors on enteric neurons
and/or activate other neurotoxic mediators in glia, this
intriguing observation indicates that glial cell activation may
have detrimental outcomes on enteric neurons. Whether
glial-induced neurodegeneration is unique to inﬂammation
of the colon or is a general feature of glial activation in the
intestine is not known. For example, glial hypertrophy and
rapid neuronal loss are common ﬁndings in ischemia-
reperfusion of the small intestine, whereas glial activation
after vagal nerve stimulation protects the small intestine
from acute trauma. Glial-derived nitric oxide also plays an
important regulatory role in mucosal ﬂuid secretion during
inﬂammation of the colon, but not in more proximal tissues.
Because enteric glia represent a highly heterogeneous cell
population, it will be important to establish whether all glial
subtypes relay purinergic death signals to enteric neurons.
Because inﬂammation and infection often preferentially
target the mucosa, for example, in ulcerative colitis, it will be
interesting to learn whether submucosal neurons are
affected similarly. It also will be important to establish
whether enteric neuronal precursors are targets of these
purinergic death signals.
In conclusion, enteric glial cell activation in response to
central or local epigenetic signals may have evolved as
pathogenic triggers of neurodegeneration in the intestine.
Further studies are needed to investigate whether these
previously unappreciated cell death responses represent a
potential barrier to postnatal enteric neural stem cell
programs.TOR C. SAVIDGE, PhD
Department of Pathology and Immunology
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